Log in

Regulus Therapeutics Price Target & Analyst Ratings (NASDAQ:RGLS)

$0.69
-0.01 (-1.43 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$0.68
Now: $0.69
$0.73
50-Day Range
$0.59
MA: $0.71
$0.85
52-Week Range
$0.50
Now: $0.69
$3.14
Volume102,433 shs
Average Volume76,943 shs
Market Capitalization$14.38 million
P/E RatioN/A
Dividend YieldN/A
Beta1.89

Analyst Ratings

Regulus Therapeutics (NASDAQ:RGLS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Regulus Therapeutics in the last 12 months. Their average twelve-month price target is $1.50, suggesting that the stock has a possible upside of 117.27%. The high price target for RGLS is $2.00 and the low price target for RGLS is $1.00. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.252.252.002.00
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $1.50$1.50$1.25$1.33
Price Target Upside: 117.27% upside150.00% upside4.17% upside20.12% upside

Regulus Therapeutics (NASDAQ:RGLS) Consensus Price Target History

Regulus Therapeutics (NASDAQ:RGLS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/6/2019HC WainwrightInitiated CoverageBuy$2.00High
8/13/2019Needham & Company LLCReiterated RatingHoldHigh
5/16/2019WedbushReiterated RatingHold$1.00Low
3/19/2019Wells Fargo & CoLower Price TargetMarket Perform ➝ Market Perform$6.00 ➝ $1.50High
7/10/2018Leerink SwannDowngradeOutperform ➝ Market PerformLow
7/6/2018B. RileyLower Price TargetNeutral ➝ Neutral$1.00 ➝ $0.50High
3/8/2018BMO Capital MarketsSet Price TargetMarket Perform ➝ Hold$1.00High
1/16/2018Chardan CapitalReiterated RatingNeutralLow
(Data available from 10/19/2017 forward)
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Featured Article: What is operating income?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel